<![CDATA[Hansa Biopharma - Analytikere og concensus]]>The Company collected consensus is now available on our web ahead of Q1 Earnings of Thursday

Link Preview Image
Analysts and consensus | Hansa Biopharma

We develop innovative immunomodulating therapies with the potential to transform the lives of people affected by rare immunologic conditions.

favicon

(www.hansabiopharma.com)

112080_104110922_10224130035184503_7865807028083263106_n.jpg

]]>https://dev.proinvestor.com/forum/topic/444975/hansa-biopharma-analytikere-og-concensusRSS for NodeThu, 25 Jun 2026 16:17:17 GMTMon, 17 Apr 2023 11:16:04 GMT60